Axcelis Technologies (NASDAQ:ACLS – Get Free Report) had its price objective increased by Bank of America from $90.00 to $100.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “underperform” rating on the semiconductor company’s stock. Bank of America‘s price target suggests a potential upside of 4.47% from the company’s previous close.
Several other brokerages have also commented on ACLS. DA Davidson raised their price objective on shares of Axcelis Technologies from $90.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. Zacks Research lowered Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a research report on Friday, December 5th. B. Riley dropped their price target on Axcelis Technologies from $85.00 to $84.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Monday, December 22nd. Finally, Wall Street Zen downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Saturday, January 3rd. Three investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $100.80.
Read Our Latest Stock Analysis on ACLS
Axcelis Technologies Stock Performance
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last issued its quarterly earnings data on Tuesday, November 4th. The semiconductor company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.01 by $0.20. The business had revenue of $213.61 million during the quarter, compared to analyst estimates of $200.06 million. Axcelis Technologies had a net margin of 15.93% and a return on equity of 14.58%. The company’s revenue for the quarter was down 16.8% on a year-over-year basis. During the same period in the prior year, the business earned $1.49 EPS. Axcelis Technologies has set its Q4 2025 guidance at 1.120-1.120 EPS. As a group, research analysts predict that Axcelis Technologies will post 2.55 EPS for the current year.
Insider Buying and Selling
In other news, Director Jorge Titinger sold 2,000 shares of the stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $86.05, for a total value of $172,100.00. Following the sale, the director directly owned 7,477 shares of the company’s stock, valued at approximately $643,395.85. This represents a 21.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Gerald M. Blumenstock sold 3,034 shares of the firm’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $89.46, for a total value of $271,421.64. Following the transaction, the executive vice president owned 18,661 shares of the company’s stock, valued at $1,669,413.06. The trade was a 13.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.48% of the stock is owned by company insiders.
Institutional Trading of Axcelis Technologies
Several institutional investors have recently bought and sold shares of the company. American Century Companies Inc. increased its stake in Axcelis Technologies by 45.5% during the 2nd quarter. American Century Companies Inc. now owns 1,659,463 shares of the semiconductor company’s stock valued at $115,648,000 after purchasing an additional 518,968 shares in the last quarter. LSV Asset Management purchased a new stake in shares of Axcelis Technologies during the third quarter valued at approximately $30,747,000. Invesco Ltd. increased its position in shares of Axcelis Technologies by 176.6% during the third quarter. Invesco Ltd. now owns 386,735 shares of the semiconductor company’s stock valued at $37,761,000 after acquiring an additional 246,939 shares in the last quarter. Millennium Management LLC increased its position in shares of Axcelis Technologies by 143.8% during the third quarter. Millennium Management LLC now owns 261,776 shares of the semiconductor company’s stock valued at $25,560,000 after acquiring an additional 154,381 shares in the last quarter. Finally, Boston Partners raised its holdings in Axcelis Technologies by 42.3% in the 2nd quarter. Boston Partners now owns 474,043 shares of the semiconductor company’s stock worth $33,616,000 after acquiring an additional 141,004 shares during the last quarter. 89.98% of the stock is owned by hedge funds and other institutional investors.
Axcelis Technologies Company Profile
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Read More
- Five stocks we like better than Axcelis Technologies
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
